The Women’s Health Initiative Dietary Modification Trial examined the long-term influence of low-fat eating patterns on the breast cancer mortality rate.
The Women’s Health Initiative Dietary Modification (WHI DM) Trial examined the long-term influence of low-fat eating patterns on the breast cancer mortality rate.
The trial incorporated 48,835 postmenopausal women without breast cancer from 1993 to 1998, who were assigned to 40 US clinical centers for either a dietary intervention or to a usual diet comparison group. The dietary intervention group attempted to reduce fat intake to 20% of energy and to increase the consumption of fruits, vegetables, and grains. Weight loss and calorie restrictions were not goals of the intervention.
“WHI DM is a primary prevention trial; however, in adjuvant breast cancer trials, death as a result of all causes measured from diagnosis (breast cancer overall survival) is considered an important clinical end point,” the authors wrote.
The dietary intervention group participated in 18 group sessions with certified nutritionists in the first year, along with quarterly maintenance meetings throughout the entire period, while the comparison group received written diet education materials. Throughout the study, participants also provided food frequency questionnaires in a rotating system.
The study resulted in no statistically significant difference in breast cancer mortality rates between the groups, despite the lower number of deaths that occurred in the dietary intervention group. During the same period, the number of deaths after breast cancer significantly decreased with a hazard ratio (HR) of 0.65.
“In addition, accurate determination of cause of death after breast cancer can be difficult given the potential interaction between common comorbidities and cancer therapies, such as cardiac disease after anthracycline, trastuzumab, or radiation therapy,” the researchers wrote. “Thus, the actual breast cancer mortality rate likely lies between the attributed rate, on the basis of medical record review, and the rate that considered all deaths after breast cancer.”
Furthermore, during the 16.1-year follow-up period, the breast cancer mortality rate was also significantly reduced with the dietary group (HR, 0.82), but no reduction in breast cancer incidence was found. Overall, there were 9% fewer deaths resulting from breast cancer and 18% fewer deaths occurring after breast cancer in the dietary group.
The researchers suggest further research on other lifestyle factors that can contribute to the incidence and outcomes of breast cancer with a low-fat dietary pattern as a starting point.
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Combatting Misconceptions of Clinical Trials to Improve Patient Participation
October 16th 2024There are many misconceptions patients might have about clinical trials that prevent them from participating, and it’s important to understand what they are in order to overcome them, said Terry L. Keys, of University of Kentucky Markey Cancer Center.
Read More
Creating Equitable Cancer Care for Americans of Asian and Pacific Islander Heritage
October 15th 2024Naoto T. Ueno, MD, PhD, FACP, of the University of Hawai’I Cancer Center outlines the underrepresentation in clinical trials, the lack of permanent medical oncologists, and issues of trust affecting care for the populations living in Hawaii.
Read More